In patients with CAD after PCI, ticagrelor plus aspirin could lower the recurrence risk of MACCE in both CYP2C19 LOF allele carrier and non-carrier compared with clopidogrel plus aspirin alone among non-smokers. The gene discussed is CYP2C19; the disease is coronary artery disorder.